338. The role of receptor activator of nuclear factor kappa-B (RANK) – signaling in pancreatic adenocarcinoma

2014 ◽  
Vol 40 (11) ◽  
pp. S132-S133
Author(s):  
A.T. El Gammal ◽  
N. Sander ◽  
A. Fölster ◽  
H. Friedenberger ◽  
L. Konczalla ◽  
...  
Keyword(s):  
Pancreatic Adenocarcinoma ◽  
Nuclear Factor Kappa B ◽  
Nuclear Factor ◽  
Nuclear Factor Kappa ◽  
Receptor Activator ◽  
Rank Signaling

scholarly journals Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages

2016 ◽  
Vol 25 (5) ◽  
pp. 397-399 ◽  
Author(s):  
Taku Fujimura ◽  
Yumi Kambayashi ◽  
Sadanori Furudate ◽  
Aya Kakizaki ◽  
Takanori Hidaka ◽  
...  
Keyword(s):  
Nuclear Factor Kappa B ◽  
Nuclear Factor ◽  
M2 Macrophages ◽  
Nuclear Factor Kappa ◽  
Receptor Activator ◽  
Rank Signaling

The role of nuclear factor-[kappa ]B in the biology and treatment of multiple myeloma

2001 ◽  
Vol 28 (6) ◽  
pp. 626-633 ◽  
Author(s):  
James R. Berenson ◽  
Hongjin M. Ma ◽  
Robert Vescio
Keyword(s):  
Multiple Myeloma ◽  
Nuclear Factor Kappa B ◽  
Nuclear Factor ◽  
Nuclear Factor Kappa

Osteoprotegerin (OPG) levels, total soluble receptor activator of nuclear factor-Kappa B ligand (total sRANKL) , and RANKL/OPG ratio in patients with rheumatoid arteritis

2017 ◽  
Vol 2 (1) ◽  
pp. 23-29
Author(s):  
Sousan Kolahi ◽  
Amir Ghorbanihaghjo ◽  
Nadereh Rashtchizadeh ◽  
Alireza Khabbazi ◽  
Mehrzad Hajialilo ◽  
...  
Keyword(s):  
Nuclear Factor Kappa B ◽  
Nuclear Factor ◽  
Soluble Receptor ◽  
Nuclear Factor Kappa ◽  
Receptor Activator
Sign in / Sign up

Export Citation Format

Share Document